Skip to main content
OpenTrials

Clinical trial condition

Uterine Cervical Neoplasms

Explore clinical trials studying Uterine Cervical Neoplasms. Study availability and eligibility vary by location and protocol.

1,588 public trials 355 recruiting studies
Refine in advanced search Browse all conditions

Uterine Cervical Neoplasms trial results

Completed

Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix

NCT00005965

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Saint Vincent Catholic Medical Center of New York New York, United States
  • NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States
  • New York Presbyterian Hospital - Cornell Campus New York, United States
  • Mount Sinai Medical Center, NY New York, United States
View Trial Details
Completed

Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer

NCT00002536

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Southern California Permanante Medical Group Bellflower, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Community Hospital of Los Gatos Los Gatos, California, United States
View all 41 locations
View Trial Details
Completed

Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix

NCT00003078

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
View all 66 locations
View Trial Details
Completed

EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer

NCT00049231

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Colorado Gynecologic Oncology Group P.C. Denver, Colorado, United States
  • Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia, Missouri, United States
  • Oklahoma University Medical Center Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix

NCT00003017

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Hunterdon Regional Cancer Center Flemington, New Jersey, United States
  • CCOP - Northern New Jersey Hackensack, New Jersey, United States
  • NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States
View Trial Details
Completed

Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer

NCT00005837

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
View all 72 locations
View Trial Details

Related conditions